The relatively indolent clinical course, which would be unusual for AITL/TCL‐TFH, albeit it has been reported previously,3 taken in the context of a clonal, EBV–, BRAF‐mutant NMZL‐like proliferation, added to the diagnostic difficulty. The gene discussed is BRAF; the disease is angioimmunoblastic T-cell lymphoma.